Background: Diabetes is one of the most prevalent and costly chronic diseases in the United States. Objectives: To analyze the risk of developing diabetes and the annual cost of diabetes for a US general population. Methods: Data from the Medical Expenditure Panel Survey, 2008Survey, to 2012, were used to analyze 1) probabilities of developing diabetes and 2) annual total health care expenditures for diabetics. The age-, sex-, race-, and body mass index (BMI)-specific risks of developing diabetes were estimated by fitting an exponential survival function to age at first diabetes diagnosis. Annual health care expenditures were estimated using a generalized linear model with log-link and gamma variance function. ) obesity, is associated with a substantial increase in the risk of developing diabetes and imposes a large economic burden.
Introduction
Diabetes is one of the most prevalent and costly chronic diseases in the United States. In 2011, it was estimated that 20.8 million US adults (9%) lived with diabetes [1] , and about 1.5 million new cases of diabetes were diagnosed [2] . Diabetes is not only detrimental to the health and productivity of those who suffer from it but also incurs substantial economic burden to them and to society. The total estimated cost of diagnosed diabetes in 2012 was $245 billion, including $69 billion in reduced productivity and $176 billion in direct medical costs [3] .
Obesity is a significant risk factor of diabetes. It has been shown that 87% of US adults with diabetes are overweight or obese (body mass index [BMI] Z 25 kg/m 2 ) [4] . Moreover, previous studies have shown a strong association of overweight and obesity with the incidence of type 2 diabetes [5] and diabetesrelated comorbidities [6] , which lead to higher medical expenses for the obese population compared with the normal-weight population [7] . Therefore, it is important to better understand the association of obesity with the risk of developing diabetes and the medical expenditures associated with diabetes and diabetes-related comorbidities.
Previous studies have investigated the association of obesity with diabetes and suggested a positive relationship between obesity and the incidence of diabetes. Geiss et al. [8] analyzed the association between the time trend of obesity and the incidence of diabetes from 1980 to 2012. Narayan et al. [9] estimated the incidence of diabetes to predict the remaining lifetime risk of developing diabetes by BMI category, rather than the annual risks of developing diabetes. Using nationally representative data from 1997 to 2000, Leung et al. [10] computed the life-years lost and the lifetime health care expenditures associated with diabetes by age, sex, race, and BMI category. In this study, we report the annual risks of developing diabetes by age, sex, race, and BMI category, the results of which can be used to inform future cost-effectiveness analyses of obesity prevention programs or diabetes prevention and control interventions.
There is a substantial amount of literature addressing the costs associated with diabetes. Trogdon and Hylands [11] analyzed annual medical expenditures as a function of duration of diabetes. Zhuo et al. [12] computed the excess medical spending attributable to diabetes, differentiating by types of medical services. Other studies have shown that BMI is associated with increased medical expenditures for patients with and without diabetes. A study in Spain showed that an increase in BMI among patients with type 2 diabetes was associated with an increase in direct health care costs [13] . Cawley et al. [14] used an instrumental variable approach to examine the causal relationship between BMI and savings in medical expenditures by diabetes status. Our study will be the first to compare the differences in total health care expenditures by diabetic status across BMI category.
The purpose of this study was to examine the age-, sex-, and race-specific risks of diabetes and the annual total health care expenditures by BMI category for both those with and without diabetes in the US population. Because obesity is one of the most important modifiable risk factors of diabetes, our study findings will help inform future decision analyses in diabetes prevention studies when the BMI category is considered an important determinant of outcomes.
Methods

Data
We used data from the Medical Expenditure Panel Survey (MEPS) Household Component (HC) Full-Year Consolidated Data files collected by the Agency for Healthcare Research and Quality and the National Center for Health Statistics [15] . The MEPS is a complex multistage probability sample design data set that provides nationally representative data containing detailed information such as health care use, expenditures, sources of payment, and health insurance coverage for the US civilian noninstitutionalized population [16] . In addition, information regarding respondents' health status, demographic characteristics, and insurance coverage is provided in the HC data files. The MEPS HC data files were merged with the Medical Conditions files to supplement the data set with diabetes-related comorbidities.
Analytic Cohort
We targeted US adults aged 20 years or older in our study cohort. The analytic cohort was assembled by excluding the following people: 1) individuals with missing values on the target variables; 2) underweight (BMI o 18.5 kg/m 2 ) individuals, because they may include heavy smokers or persons with severe chronic diseases and malignancies [17] ; 3) women pregnant at the time of survey, because their BMI levels are unstable during pregnancy [17, 18] ; 4) individuals diagnosed with cancer because their BMI levels are less stable due to cancer treatment and appetite loss [18, 19] ; and 5) those with diabetes who reported inconsistent diabetes status across MEPS 2008 to 2012.
Models and Analyses
The MEPS collected information about diabetes by asking participants whether they had ever been diagnosed with diabetes and when their first diagnosis was. The probabilities of developing diabetes were estimated by fitting an exponential survival function to age at first diabetes diagnosis separately for males and females [10] [20] on the basis of self-reported BMI at survey.
We then predicted the probabilities of developing diabetes for each individual. We ran a regression of BMI at survey on duration of diabetes, age category, and race category separately for males and females (see details in part A of the Appendix in Supplemental Materials found at 10.1016/j.jval.2016.08.735). We then predicted BMI at diabetes diagnosis for each individual with diabetes. On the basis of these predicted BMIs at diagnosis for individuals with diabetes and BMI at survey for individuals without diagnosis, we grouped the population into the five BMI categories using the aforementioned criteria [20] . The predicted probabilities of developing diabetes (computed according to the model described in the previous paragraph) were then averaged across individuals in each BMI category to obtain the mean probabilities of developing diabetes for each BMI category.
Annual total health care expenditures were estimated using a generalized linear model with log-link and gamma variance function [21] . We controlled for diabetes status, duration of diabetes, duration of diabetes-squared, age (at survey), agesquared, interactions between diabetes status with age and with age-squared, sex, race (white, black, Hispanic, Asian, and other), education level (less than high school, high school diploma, college degree, graduate degree, and other degree), household income level as a percentage of the federal poverty level (o100%, 100%-199%, 200%-399%, and Z400%), census region (northeast, midwest, south, and west), primary source of health insurance (Medicaid, Medicare, private insurance, other public insurance, and uninsured), diabetes-related comorbidities (heart disease, stroke, congestive heart failure, hypertension, high cholesterol, and renal failure), BMI category (normal weight, overweight, and class I, II, and III obesity) on the basis of self-reported BMI at survey, current smoker or not, survey year dummies (2009, 2010, 2011, and 2012) , and interactions between BMI categories and diabetes status. We added the last covariate in addition to the covariates included in the study by Trogdon and Hylands [11] to test for differences in the effect of BMI categories on health care expenditures between individuals with and without diabetes.
An alternative model using a two-part model with a logit model in the first part and a separate generalized linear model with log-link and gamma variance function in the second part was also constructed. Sensitivity analyses using the inverse of BMI as a continuous variable in the cost estimation were also performed to examine whether our main conclusion was sensitive to the specification of BMI as a categorical versus a continuous variable. We computed health care cost differentials associated with diabetes by taking the differences between the predicted health care expenditures of those with and without diabetes for each age, sex, race, and BMI category.
The MEPS data do not allow us to differentiate between type 1 and 2 diabetes. Because 78% of diabetes incidence before the age of 20 years is type 1 diabetes [22] , we conducted sensitivity analyses for the risks of developing diabetes and costs associated with diabetes by excluding diabetic patients who reported to be younger than 20 years at diabetes diagnosis.
Statistical Analyses
We merged multiple years (2008-2012) of the MEPS data to increase the sample size for analysis, following the analytic guidelines published on the MEPS Web site. A common variance structure is specified across years that accurately reflects the complex sample design of the MEPS [23] . The complex sampling designs in the MEPS were adjusted for in all the analyses. All dollar values were deflated using the Personal Health Care Expenditure Price Index and are presented at 2012 price levels [24] . STATA version 12 (StataCorp, College Station, TX) was used in all the analyses. Figure 1 . Among the population represented by the analytic cohort, 8.1% (N ¼ 12,329,131) had diabetes. Within the population, the average age of those with diabetes was 59 years compared with 45 years for those without diabetes. The average age at diabetes diagnosis in our sample 
Results
Analytic Cohort
Variable
Those with Diabetes Those without diabetes 
was 49 years, and the average duration of diabetes was 10 years. The average annual total health care expenditures in 2012 dollars were $10,015 for those with diabetes and $3,626 for those without diabetes. Individuals with diabetes were poorer, had lower education levels, and were more likely to be minorities, to be obese, and to have diabetes-related comorbidities when compared with individuals without diabetes.
Risk of Developing Diabetes
The predicted annual probabilities of developing diabetes by age, sex, race, and BMI category on the basis of the predicted BMI at diagnosis for those with diabetes and BMI at survey for those without diabetes are presented in Figure 2 . Hazard ratios for developing diabetes obtained from the survival analysis are presented in Appendix (Fig. 2) . The probabilities of developing diabetes increased monotonically with BMI category. The average probability of developing diabetes (an arithmetic mean over age, sex, and race) for normal-weight individuals was 0.11% compared with 0.69% for class III obese individuals (a more than 6 times increase in risks for class III obese individuals). Females had slightly higher risks of developing diabetes before the age of 40 years than did males. After the age of 40 years, however, males had slightly higher probabilities of developing diabetes than did females over all BMI categories except for class III obesity. For people older than 40 years, class III obese males had significantly higher probabilities of developing diabetes compared with women of the same BMI category. We also found that the probabilities of developing diabetes increased monotonically with age. On average, individuals aged 70 years or older had about 9 times higher risks of developing diabetes compared with individuals aged 20 to 29 years (0.62% vs. 0.07%). Racial groups other than whites or blacks had the highest risk of developing diabetes (0.44%), followed by blacks (0.37%) and whites (0.26%).
The results from the sensitivity analysis for excluding diabetic patients who reported to be younger than 20 years at diabetes diagnosis show that the patterns of developing diabetes are preserved for most of the age at survey groups except the age group 20 to 29 years because of the reduced size of this age group resulting from this exclusion (see Appendix Fig. 1 
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Health Care Expenditures Associated with Diabetes
Results from our cost estimation show that those with diabetes had 127% higher annual health care expenditures than those without diabetes regardless of age (see Appendix Table 2 in Supplemental Materials found at http://dx.doi.org/10.1016/j.jval. 2016.08.735). The rate of increase in total annual health care expenditures slowed with age and duration of diabetes. Nevertheless, the interactions for diabetes and age were insignificant, which suggested that there was no significant difference in the Fig. 2 -Mean predicted probabilities of developing diabetes by age, sex, race, and BMI category on the basis of predicted BMI at diagnosis for individuals with diabetes and BMI at survey for individuals without diabetes. BMI, body mass index.
V A L U E I N H E A L T H 2 0 (
association of age and total annual health care expenditures between those with and without diabetes. Using population age 50 years as an example, Figure 3 shows the predicted annual total health care expenditures by 1) diabetes status; 2) sex and diabetes status; 3) race and diabetes status; and 4) BMI category and diabetes status (for population ages 30, 40, 50, 60, and 70 years, see Appendix Table 3 in Supplemental Materials found at 10. 1016/j.jval.2016.08.735). The mean predicted annual total health care expenditures were $13,581 for those with diabetes and $3,954 for those without diabetes aged 50 years, with a differential of $9,627.
Our results show that females had significantly higher total annual health care expenditures than males among those with and without diabetes. At age 50 years, nondiabetic men spent $3,251 on annual health care compared with $11,252 spent by diabetic men, whereas nondiabetic women spent $4,684 compared with $15,961 spent by diabetic women.
Overweight individuals had a yearly marginal effect of À$65 compared with normal-weight individuals, although this difference was not statistically significant (Table 2) . Class II and class III obese individuals had significantly higher annual health care expenditures than normal-weight individuals. Compared with their normal-weight counterparts, class II obese individuals spent about 12% more and class III obese individuals spent about 20% more (see Appendix Table 2 in Supplemental Materials), which correspond to average marginal cost of $628 for class II obese individuals and $756 for class III obese individuals (Table 2) . Our results also show that interactions between diabetes status and BMI category were insignificant, which suggested that there was no significant difference in the effects of BMI category on annual total health care expenditures between those with and without diabetes. In terms of the health care cost differentials between those with and without diabetes, at age 50 years, class I obese individuals had the lowest differentials ($7,591), followed by the overweight group ($8,607). Class II obese individuals had the largest health care cost differentials associated with diabetes ($12,907) among all BMI categories (see Appendix Table 3 in Supplemental Materials).
The results of the sensitivity analyses using the two-part model (see Appendix Tables 4 and 5 
Discussion
We analyzed the burden of diabetes by investigating the associations of BMI category with the risk of developing diabetes and annual health care expenditures associated with diabetes. We observed a more than 6 times increase in probabilities of developing diabetes for class III obese individuals compared with normal-weight individuals. We also found that class II and class III obese individuals spent, respectively, about 12% and 20% higher than normal-weight individuals.
Our study differed from others in that we estimated the probabilities of developing diabetes directly rather than on the basis of the incidence rate of diabetes [8, 9, 25] , which has often been used to approximate the probabilities of developing diabetes in decision analyses. Probability describes the likelihood of an event occurring, whereas the incidence rate describes the proportion of new cases in a given time period. Therefore, a direct comparison cannot be made between these two measures. Moreover, instead of focusing on the time trend of the risk of developing diabetes, as was done by Geiss et al. [8] , we estimated and predicted the probabilities of developing diabetes by age, sex, race, and BMI category, which were not previously reported. Our probability estimates can be directly used to inform decision analysis models regarding diabetes prevention and interventions when BMI is considered an important determinant of the outcomes of the study.
Our results are consistent with those presented in the study by Geiss et al. [8] in several ways: 1) Geiss et al. showed that males and females had similar diabetes incidence since 1980. We too found that males and females had similar probabilities of developing diabetes over all BMI categories except for class III obese individuals; 2) We demonstrated that the probabilities of developing diabetes increased with age. In particular, individuals aged 70 years or older had a nearly 9 times higher chance of developing diabetes compared with individuals aged 20 to 29 years. This result is qualitatively comparable with that of Geiss et al., in which they showed that diabetes incidence increased with age category, and individuals aged 65 to 79 years had an approximately 4 times higher incidence rate compared with individuals aged 20 to 44 years; 3) Our results suggested that races other than black and white were more likely to develop diabetes than blacks, followed by whites. The average probabilities over age, sex, and BMI category were 0.44% for other races, 0.37% for blacks, and 0.26% for whites. This finding is consistent with Geiss et al. who showed that Hispanics had higher diabetes incidence than non-Hispanic blacks and that non-Hispanic blacks had higher diabetes incidence than non-Hispanic whites from 2008 to 2012.
Our cost estimation is comparable with that of Trogdon and Hylands [11] . We found that class II and class III obese individuals spent, respectively, about $628 and $756 more on health 
care annually than normal-weight individuals. Nevertheless, our estimate of the average marginal effect of one additional year of diabetes duration on total health care expenditures was $160, 1.8 times higher than that estimated by Trogdon and Hylands [11] ($75 in 2005 dollars, i.e., $90 in 2012 dollars), in which they used MEPS data from 2000 to 2004. As suggested by Trogdon and Hylands [11] and Zhuo et al. [12] , the increase in diabetes costs over time was largely due to higher prescription drug expenditures, which might explain the higher cost found in our study. We found that those with diabetes aged 50 years spent an excess of $9627 on total annual health care compared with those without diabetes at the same age. Although this additional cost may be underestimated given the inclusion of renal failure as a covariate in our study, this estimate was still higher than that predicted by Zhuo et al. [12] ($5378 in 2012 dollars). The difference can be explained by the following reasons. First, in their study, duration of diabetes was not considered in the model, which could underestimate the association of diabetes with health care costs, because the costs increase with time since diagnosis [11] . Second, Zhuo et al. [12] used MEPS data from 2010 to 2011 in their analysis, whereas our study used data from 2008 to 2012.
Our results were also consistent with those of Cawley et al. [14] in several ways. Using the restricted-use version of the MEPS data, Cawley et al. established a causal relationship between BMI and medical expenditures by using BMI and BMI-squared of the respondent's eldest biological child as an instrumental variable for the respondent's BMI and BMI-squared. They found that individuals with class I obesity do not have elevated health care costs, but health care costs rise rapidly with BMI in the range of class II and class III obesity, which is consistent with our findings. Estimating separately for those with and without diabetes, they found that medical care costs for those with diabetes were greater than for those without diabetes at every unit of BMI. We found in our estimation that the highest differentials of the mean predicted annual total health care expenditures between those with and without diabetes were in individuals with class II and III obesity.
Our study has several strengths. First, we used the most recent MEPS data at the time of this study to provide the most up-to-date estimates of the probabilities of developing diabetes and the total annual health care expenditures. Second, we showed that obesity was an important factor in developing diabetes (class III obese individuals have a more than 6 times higher risk of developing diabetes compared with normal-weight individuals). Third, we documented the economic burden of diabetes and obesity by comparing the mean predicted total annual health care expenditures jointly by BMI category and diabetes status. Last, the metrics that we reported can be directly applied to decision modeling when BMI is considered an important factor.
Our study also has several limitations. First, our study relies on self-reported information, which may be subject to reporting bias. For example, systematic self-reported error in BMI can lead to an overestimation of the health care expenditures associated with obesity [26] . Moreover, self-reported information on diabetes diagnosis might not capture the entire diabetes population, in Fig. 3 -Mean predicted annual total health care expenditures (2012 dollars) for those with and without diabetes aged 50 years. All the graphs were generated from the result of the multivariable analysis, using the generalized linear model controlling for age, age-squared, race (white, black, Hispanic, Asian, and other), education level (less than high school, high school diploma, college degree, graduate degree, and other degree), household income level as a percentage of the federal poverty level (o100%, 100%-199%, 200%-399%, Z400%), census region (northeast, midwest, south, and west), primary source of health insurance (Medicaid, Medicare, private insurance, other public insurance, and uninsured), diabetes-related comorbidities (heart disease, stroke, congestive heart failure, hypertension, high cholesterol, and renal failure), year dummies (2009, 2010, 2011, and 2012 ), and present smoker or not. Results for mean predicted annual total health care expenditures (2012 dollars) for those with and without diabetes aged 40, 50, and 60 years are presented in Appendix Table 3 in Supplemental Materials found at http://dx.doi.org/10.1016/j.jval.2016.08.735. particular, people with undiagnosed diabetes. The direction of this bias is ambiguous because those with undiagnosed diabetes are likely in poorer health, which would tend to increase the total health care expenditures; yet because people with undiagnosed diabetes likely did not receive diabetes-specific treatment, this lack of treatment could lead to lower total health care expenditures. Also, it has been shown that the accuracy of self-reporting data for diabetes is reasonably high in population surveys [27] . Second, missing information of unobserved diabetic patients who died before the time of survey may create bias similar to survivorship bias because of potential systematic differences between the observed and the unobserved diabetic patients in age at diabetes diagnosis. To our knowledge, however, there is no clear evidence to suggest such systematic differences. Therefore, the direction of bias of such selection of survivorship in our study is ambiguous. Finally, our work studied the risks and costs associated with diabetes. The readers should be cautious not to interpret our results as causal.
Conclusions
We examined the association of obesity with risk and cost of diabetes by analyzing the probabilities of developing diabetes and the total annual health care expenditures for those with and without diabetes by BMI categories. We showed that obesity, in particular, class II and III obesity, is associated with a substantial increase in the risk of developing diabetes and imposes a large economic burden on health care expenditures. Our study highlights the importance of obesity on the burden of diabetes in the United States. Our results can inform policymakers about the potential benefits of reducing the burden of diabetes by reducing obesity. The metrics that we reported can be directly applied to decision models in diabetes prevention studies when BMI is considered an important factor.
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